Trius Therapeutics
Registration and award facts
- Net obligations since FY2008
- $33.76M
- $33,760,654under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 3
- with positive net obligations
- Latest action
- Apr 20, 2017
Registration
- SAM.gov registration
- No SAM.gov registration on file; known from federal award records
† FY2026 obligations (provisional; DoD awards signed after Jul 27, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI MCPHH5DJ3GR6. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2008. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2017: -$1 (de-obligation)
- FY2015: -$2,779,098 (de-obligation)
- FY2013: $3,564,704
- FY2012: $5,500,000
- FY2011: $3,107,430
- FY2010: $12,846,342
- FY2008: $11,521,277
Total across 7 fiscal years: $33,760,654
Net de-obligation in that fiscal year (obligations withdrawn).
Top awarding agencies
- Department of Health and Human Services$26,487,749, 78.5%
- Department of Defense$7,272,905, 21.5%
Top awarding sub-agencies
- National Institutes of Health$26,487,749, 78.5%
- Defense Threat Reduction Agency$7,272,905, 21.5%
Top NAICS by obligations
- 541711Research and development in biotechnology$33,760,654, 100%
Top product and service codes by obligations
- AN12Biomedical (applied/exploratory)$32,914,778, 97.5%
- AN11R&d- medical: biomedical (basic research)$845,876, 2.5%
Capabilities
SBA certifications
No certification in the SBA profile data.
Contracts
Latest awards and orders
- HDTRA110C0004Definitive contractDepartment of DefenseDefense Threat Reduction AgencyLatest action
- HHSN272201300018CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
- HHSN272200800042CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
Contact Info
SAM.gov registration for Trius Therapeutics lists a physical address. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
N/A, N/A, N/A
Additional Details
Trius Therapeutics has no active federal suspension or debarment on record in SAM.gov.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is not publicly displayed
Registration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation